857410P

IG7

Avanti Research^™ - A Croda Brand, powder

• 同義詞: N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-5-methoxy-1H-indole-2-carboxamide
• 經驗公式（希爾表示法）: C₂₇H₄₃N₃O₄
• CAS號碼: 2132345-13-0
• 分子量：: 473.65
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 化驗: 99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 mg (857410P-5mg); pkg of 1 × 5 mg (857410P-5mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand
• 脂質類型: bioactive lipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC(OC)=C2)=O)C(NCCCCCCCCCCCCC)=O
• InChI 密鑰: RAXJRRQLMVPSON-NLFFAJNJSA-N

描述

一般說明

IG7 is a ceramide analog.

生化／生理作用

IG7 is potent in enhancing Fas ligand (FasL) induced apoptosis in colon carcinoma cells SW480 and RKO. IG7 enhances FasL mediated phosphorylation of p38 and janus kinase (JNK). IG7 enhances nuclear factor-kappa B (NF-κB) activation by FasL. IG7 exhibits low toxicity.

包裝

5ML Glass Amber Screw Cap Vial (857410P-1MG)

5ML Glass Amber Screw Cap Vial (857410P-5MG)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable